Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$60.14 - $75.36 $176,811 - $221,558
2,940 Added 40.64%
10,175 $661,000
Q4 2023

Jan 16, 2024

BUY
$42.85 - $69.5 $118,351 - $191,959
2,762 Added 61.75%
7,235 $494,000
Q3 2023

Oct 12, 2023

BUY
$49.5 - $66.6 $221,413 - $297,901
4,473 New
4,473 $232,000

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.